Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
TINAVI Medical Technologies Co., Ltd. specializes in the entire lifecycle of orthopedic robotic technology, encompassing its research, development, production, and practical clinical application. The company's flagship offering is TiRobot, a sophisticated robotic system engineered to assist in orthopedic surgical procedures related to both spine and trauma. Established in 2010, TINAVI Medical Technologies operates from its headquarters in Beijing, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of 688277.SS is 20.6 and suggests 31.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to